Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Intellia Therapeutics, Inc. securities between June 30, 2024 and January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback